Susan D. DeVore
CIK: 0001587697
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 26, 2026UNM
Unum Group
Award(A)Direct2.2K shares- - May 15, 2026SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.3K shares- - May 13, 2026ELV
Elevance Health, Inc.
Award(A)Direct563 shares- - Apr 30, 2026SOLV
Solventum Corp
Exercise(M)Direct3.4K shares- - Mar 27, 2026SOLV
Solventum Corp
Exercise(M)Direct2K shares- - Aug 19, 2025ELV
Elevance Health, Inc.
Purchase(P)Direct1.2K shares at avg. $312.15$375K - May 22, 2025UNM
Unum Group
Award(A)Direct2.2K shares- - May 14, 2025ELV
Elevance Health, Inc.
Award(A)Direct601 shares- - May 13, 2025SOLV
Solventum Corp
Exercise(M)Direct3.6K shares- - Apr 30, 2025SOLV
Solventum Corp
Award(A)DirectRestricted Stock Units
3.4K shares- - Mar 3, 2025UNM
Unum Group
Sale(S)Direct4.4K shares at avg. $81.21$359K - Mar 3, 2025UNM
Unum Group
Sale(S)Direct5.6K shares at avg. $80.62$450K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  UNM Unum Group | Award(A) | 2,191 | - | $0 | Direct |
| May 15, 2026 |  SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,300 | - | - | Direct |
| May 13, 2026 |  ELV Elevance Health, Inc. | Award(A) | 563 | - | $0 | Direct |
| Apr 30, 2026 | SOLV Solventum Corp | Exercise(M) | 3,403 | - | $0 | Direct |
| Mar 27, 2026 | SOLV Solventum Corp | Exercise(M) | 1,980 | - | $0 | Direct |
| Aug 19, 2025 | ELV Elevance Health, Inc. | Purchase(P) | 1,200 | $312.15 | $374,580 | Direct |
| May 22, 2025 | UNM Unum Group | Award(A) | 2,198 | - | - | Direct |
| May 14, 2025 | ELV Elevance Health, Inc. | Award(A) | 601 | - | - | Direct |
| May 13, 2025 | SOLV Solventum Corp | Exercise(M) | 3,564 | - | - | Direct |
| Apr 30, 2025 | SOLV Solventum Corp | Award(A) Restricted Stock Units | 3,403 | - | - | Direct |
| Mar 3, 2025 | UNM Unum Group | Sale(S) | 4,423 | $81.21 | $359,178 | Direct |
| Mar 3, 2025 | UNM Unum Group | Sale(S) | 5,577 | $80.62 | $449,610 | Direct |
1-12 of 12 transactions
About DeVore Susan D.
DeVore Susan D. (SEC CIK 0001587697) files insider reports with the SEC as Director of Unum Group (UNM), Director of Solventum Corp (SOLV) and Director of Elevance Health, Inc. (ELV).
Signal8 holds 11 ownership filings by DeVore Susan D., all Form 4s, filed between Mar 4, 2025 and May 28, 2026. Those filings report 12 transactions, from Mar 3, 2025 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DeVore Susan D.'s filings is in EAGAN, MN.
Recent filings by DeVore Susan D.
- May 26, 2026: Grant or award of UNM shares (Form 4, code A).
- May 15, 2026: Grant or award of SOLV derivative securities (Form 4, code A).
- May 13, 2026: Grant or award of ELV shares (Form 4, code A).
- Apr 30, 2026: Option exercise of SOLV shares (Form 4, code M).
- Mar 27, 2026: Option exercise of SOLV shares (Form 4, code M).
Other insiders filing for Unum Group (UNM)
- Rice Walter Lynn JR, SVP, Chief Accounting Officer
- Keaney Timothy F, Director
- IGLESIAS LISA G, EVP, General Counsel
- Walker Andrew D, EVP, Chief Cust. Ops. Officer
- O HANLEY RONALD P, Director
- Matus Kristi Ann, Director